LAZERTINIB vs LENALIDOMIDE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LAZERTINIB vs LENALIDOMIDE: Safety Overview
| Metric | LAZERTINIB | LENALIDOMIDE |
|---|---|---|
| Total FAERS Reports | 352 | 349,955 |
| Deaths Reported | 15 | 35,942 |
| Death Rate | 4.3% | 10.3% |
| Hospitalizations | 83 | 86,495 |
| Average Patient Age | 66.6 yrs | 69.9 yrs |
| % Female Patients | 59.9% | 50.0% |
| FDA Approval Date | Aug 19, 2024 | Aug 3, 2023 |
| Manufacturer | Janssen Biotech, Inc. | Padagis US LLC |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |